Genetic approaches in improving biotechnological production of taxanes: An update
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Pérez Matas, Edgar
- dc.contributor.author Hidalgo Martínez, Diego
- dc.contributor.author Escrich Montañana, Ainoa
- dc.contributor.author Alcalde, Miguel Angel
- dc.contributor.author Moyano Claramunt, Elisabet
- dc.contributor.author Bonfill Baldrich, Ma. Mercedes
- dc.contributor.author Palazón Barandela, Javier
- dc.date.accessioned 2023-03-14T07:14:52Z
- dc.date.available 2023-03-14T07:14:52Z
- dc.date.issued 2023
- dc.description.abstract Paclitaxel (PTX) and its derivatives are diterpene alkaloids widely used as chemotherapeutic agents in the treatment of various types of cancer. Due to the scarcity of PTX in nature, its production in cell cultures and plant organs is a major challenge for plant biotechnology. Although significant advances have been made in this field through the development of metabolic engineering and synthetic biology techniques, production levels remain insufficient to meet the current market demand for these powerful anticancer drugs. A key stumbling block is the difficulty of genetically transforming the gymnosperm Taxus spp. This review focuses on the progress made in improving taxane production through genetic engineering techniques. These include the overexpression of limiting genes in the taxane biosynthetic pathway and transcription factors involved in its regulation in Taxus spp. cell cultures and transformed roots, as well as the development and optimization of transformation techniques. Attempts to produce taxanes in heterologous organisms such as bacteria and yeasts are also described. Although promising results have been reported, the transfer of the entire PTX metabolic route has not been possible to date, and taxane biosynthesis is still restricted to Taxus cells and some endophytic fungi. The development of a synthetic organism other than Taxus cells capable of biotechnologically producing PTX will probably have to wait until the complete elucidation of its metabolic pathway.
- dc.description.sponsorship This work was funded by the Spanish Ministry of Science and Innovation, with project number PID2020-113438RB-I00/AEI/10.13039/501100011033.
- dc.format.mimetype application/pdf
- dc.identifier.citation Perez-Matas E, Hidalgo-Martinez D, Escrich A, Alcalde MA, Moyano E, Bonfill M, Palazon J. Genetic approaches in improving biotechnological production of taxanes: An update. Front Plant Sci. 2023 Jan 26;14:1100228. DOI: 10.3389/fpls.2023.1100228
- dc.identifier.doi http://dx.doi.org/10.3389/fpls.2023.1100228
- dc.identifier.issn 1664-462X
- dc.identifier.uri http://hdl.handle.net/10230/56213
- dc.language.iso eng
- dc.publisher Frontiers
- dc.relation.ispartof Front Plant Sci. 2023 Jan 26;14:1100228
- dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/PID2020-113438RB-I00
- dc.rights © 2023 Perez-Matas, Hidalgo-Martinez, Escrich, Alcalde, Moyano, Bonfill and Palazon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Taxus spp.
- dc.subject.keyword Genetic transformation
- dc.subject.keyword Metabolic engineering
- dc.subject.keyword Paclitaxel
- dc.subject.keyword Synthetic biology
- dc.title Genetic approaches in improving biotechnological production of taxanes: An update
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion